New research reveals that individuals who discontinue new weight-loss injections like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who halt traditional lifestyle regimens.
Research printed in a major health publication points out that while overweight individuals frequently drop substantial amounts of their total mass while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals buying such drugs need to be informed of the danger of rapid weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.
Such speed of recovery means a reversion to starting weight in about 18 months.
Analyzing Therapies
The research, which examined 37 of trials involving thousands of patients, contrasted the outcomes of GLP-1 agonists with other pills.
Researchers note that people who shed pounds through lifestyle changes alone usually experience a slower creep back—around 100 grams monthly—once they finish.
The Reason for the Quick Regain
Experts believe the way of the jabs is key to understanding the amplified regain.
The injections copy a natural hormone called GLP-1, which moderates feelings of fullness.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production may cause the body to produce less of its endogenous hormone, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' means hunger is no longer kept in check, making overeating much more probable."
An Ongoing Condition?
Health authorities advise the injections for people with weight-linked health risks, accompanied by prescribed lifestyle changes.
Many experts say that, considering the significant potential of weight regain, the therapy should be considered long-term.
This perspective is echoed by drug manufacturers, who note that the findings "highlight the long-term character of excess weight," comparing it to managing conditions like high blood pressure.
User Experiences
Users who have discontinued the medication describe a sudden return of appetite.
"It felt as if a trigger that goes on and you're instantly starving," described one woman.
The struggle is compounded if users have not adopted permanent dietary or behavioural changes during treatment.
Widespread Interest
Figures indicate that millions of people in the UK have used these injections in the past year, with desire continuing to grow.
- Adoption is higher among women compared to men.
- The middle-aged age group shows the greatest level of interest.
- Many access the medications through private healthcare rather than the NHS.
Ultimately, clinicians caution that while these medications are effective agents for weight loss, they are not a magic fix and long-term success likely depends on combined behavioural changes.
